ALLO Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

03

Prezzo $1.50

Capitalizzazione di Mercato (MRQ) $518M

P/E -1.8

EPS $-0.87

Ricavi $0

ROE -59.9%

Intervallo 52 sett. $1–$4

ALLO Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

04

intervallo

barre

La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.

Performance decennale Andamento di ricavi, utile netto, margini e EPS

06

Ricavi$0

2022-12-31 → 2025-12-31

EPS$-0.87

2022-12-31 → 2025-12-31

Flusso di cassa libero$-150M

2023-12-31 → 2025-12-31

Margine netto·

2023-12-31 → 2024-12-31

Valutazione e Rapporti 07–12

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica	ALLO	media 5 anni	Mediana dei peer	Verdetto
P/E	-1.8media 5 anni ≈-1.6	≈-1.6	·	·
P/B (MRQ)	1.2media 5 anni ≈1.1	≈1.1	4.7	Sottovalutato
Prezzo / FCF (TTM)	-5.0media 5 anni ≈-2.2	≈-2.2	·	·
Prezzo / Flusso di cassa (TTM)	-5.1media 5 anni ≈-2.2	≈-2.2	·	·
Price / Tangible Book (Prezzo / Valore contabile tangibile)	1.3media 5 anni ≈1.1	≈1.1	·	·

La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica	ALLO	media 5 anni	Mediana dei peer	Verdetto
ROA	-39.6%media 5 anni ≈-43.7%	≈-43.7%	-39.6%	In linea
ROE	-59.9%media 5 anni ≈-59.3%	≈-59.3%	-45.6%	Debole
ROIC	-71.5%	·	-35.8%	Debole

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica	Tendenza 5 anni	ALLO	media 5 anni	Mediana dei peer	Verdetto
Rapporto corrente (MRQ)		10.7media 5 anni ≈9.6	≈9.6	11.8	In linea
Quick Ratio		1.6media 5 anni ≈2.0	≈2.0	11.5	Bassa liquidità

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica	Tendenza 5 anni	ALLO	media 5 anni	Mediana dei peer	Verdetto
Revenue YoY (Ricavi YoY)		-76.8%	·	·	·
Revenue CAGR 3Y (CAGR Ricavi 3Y)		-94.2%	·	·	·

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica	ALLO	media 5 anni	Mediana dei peer	Verdetto
EPS (Diluted) (EPS (Diluito))	$-0.87media 5 anni ≈$-1.43	≈$-1.43	·	·
Revenue / Share (Ricavi / Azione)	$0.00media 5 anni ≈$0.00	≈$0.00	·	·
Cash Flow / Share (Flusso di cassa / Azione)	$-0.68media 5 anni ≈$-1.07	≈$-1.07	·	·
Cash / Share (Liquidità / Azione)	$0.23media 5 anni ≈$0.36	≈$0.36	·	·

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica	Tendenza 5 anni	ALLO	media 5 anni	Mediana dei peer	Verdetto
Asset Turnover (Rotazione delle attività)		0.0media 5 anni ≈0.0	≈0.0	0.0	Debole
Revenue / Employee (Ricavi / Dipendente)		≈$0.00	·	·	·

valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

14

Sorpresa media 15.9%

Prossimo report Nov 04, 2026

Periodo	Rapporto	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	Ago 12, 2026	$-0.13	$-0.17	25.5%
31 Marzo 2026	Mag 13, 2026	$-0.18	$-0.19	7.3%
31 Dicembre 2025		$-0.17	$-0.22	23.0%
30 Settembre 2025		$-0.19	$-0.23	16.6%
30 Giugno 2025		$-0.23	$-0.28	17.6%
31 Marzo 2025		$-0.28	$-0.30	5.2%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

15

Conto Economico 15

Metrica	2025	2024	2023	2022	2021	2020	2019
Revenue	$0	$22.0K	$95.0K	$156.0K	$114M	$0	$0
R&D Expense	$150M	$192M	$243M	$256M	$220M	$193M	$145M
SG&A Expense	$57M	$65M	$72M	$79M	$74M	$65M	$57M
Operating Expenses	$209M	$273M	$328M	$336M	$294M	$258M	$202M
Operating Income	$-209M	$-273M	$-328M	$-336M	$-180M	$-258M	$-202M
Interest Expense	·	·	·	·	·	$0	$0
Other Non-op	$215.0K	$-4M	$-18M	$-9M	$-4M	$-67M	$17M
Pretax Income	$-191M	$-257M	$-327M	·	$-257M	$-250M	$-185M
Income Tax	$0	$443.0K	$0	$0	$0	$0	$-331.0K
Net Income	$-191M	$-258M	$-327M	$-340M	$-182M	$-316M	$-185M
EPS (Basic)	$-0.87	$-1.32	$-2.09	$-2.38	$-1.34	$-2.63	$-1.83
EPS (Diluted)	$-0.87	$-1.32	$-2.09	$-2.38	$-1.34	$-2.63	$-1.83
Shares (Basic)	220,622,669	194,811,756	156,931,778	143,147,165	135,820,386	120,370,177	101,061,149
Shares (Diluted)	220,622,669	194,811,756	156,931,778	143,147,165	135,820,386	120,370,177	101,061,149
EBITDA	$-197M	$-260M	$-314M	·	$-245M	$-251M	$-197M

Stato Patrimoniale 21

Metrica	2025	2024	2023	2022	2021	2020	2019
Cash & Equivalents	$52M	$75M	$83M	$62M	$173M	$183M	$175M
Short-term Investments	·	·	·	·	$284M	$645M	$355M
Prepaid Expense	$8M	$11M	$10M	$12M	$14M	$17M	$14M
Current Assets	$258M	$303M	$459M	$529M	$471M	$845M	$545M
PP&E (Net)	$73M	$86M	$99M	$113M	$123M	$119M	$56M
PP&E (Gross)	$145M	$149M	$151M	$150M	$146M	$132M	$62M
Accum. Depreciation	$73M	$63M	$51M	$37M	$23M	$13M	$5M
Intangibles	·	·	·	·	·	$0	$151.0K
Other Non-current Assets	$4M	$2M	$7M	$10M	$6M	$5M	$5M
Total Assets	$416M	$549M	$643M	$822M	$1.05B	$1.23B	$718M
Accounts Payable	$4M	$5M	$6M	$14M	$10M	$10M	$9M
Current Liabilities	$33M	$36M	$37M	$54M	$48M	$94M	$33M
Capital Leases	$75M	$83M	$88M	$95M	$70M	$51M	$51M
Other Non-current Liabilities	$16M	$8M	$5M	$6M	$8M	$3M	$4M
Total Liabilities	$123M	$127M	$131M	$155M	$126M	$148M	$89M
Common Stock	$229.0K	$212.0K	$169.0K	$144.0K	$142.0K	$140.0K	$124.0K
Retained Earnings	$-2.01B	$-1.82B	$-1.56B	$-1.23B	$-895M	$-713M	$-396M
AOCI	$269.0K	$-89.0K	$-955.0K	$-10M	$-3M	$268.0K	$1M
Stockholders' Equity	$293M	$422M	$512M	$667M	$925M	$1.01B	$629M
Liabilities + Equity	$416M	$549M	$643M	$822M	$1.05B	$1.23B	$718M
Shares Outstanding	229,413,523	212,210,597	168,642,238	144,438,304	142,623,065	140,474,305	124,267,358

Flusso di cassa 15

Metrica	2025	2024	2023	2022	2021	2020	2019
D&A	$12M	$14M	$14M	$14M	$10M	$7M	$5M
Stock-based Comp	$38M	$52M	$66M	$84M	$81M	$65M	$46M
Deferred Tax	$0	$443.0K	$0	·	·	·	·
Amort. of Intangibles	·	·	·	$0	$0	$151.0K	$603.0K
Restructuring	$5M	·	·	·	·	·	·
Other Non-cash	$-8M	$-9M	$9M	·	$-19M	$62M	$-3M
Operating Cash Flow	$-149M	$-200M	$-238M	$-221M	$-185M	$-115M	$-137M
CapEx	$386.0K	$694.0K	$2M	$5M	$21M	$66M	$51M
Investing Cash Flow	$96M	$76M	$163M	$106M	$164M	$-505M	$164M
Stock Issued	·	·	$91M	$0	$0	$596M	$0
Net Stock Activity	·	·	$91M	·	$0	$622M	$54M
Financing Cash Flow	$30M	$117M	$96M	$3M	$12M	$634M	$59M
Net Change in Cash	$-24M	$-8M	$21M	$-111M	$-9M	$13M	$86M
Free Cash Flow	$-150M	$-201M	$-239M	·	$-206M	$-181M	$-188M
Levered FCF	·	·	·	·	·	$-181M	$-188M

Redditività 7

Metrica	2025	2024	2023	2022	2021	2020	2019
Operating Margin	·	-1241813.6%	-344986.3%	·	-664.6%	·	·
Net Margin	·	-1170863.6%	-344489.5%	·	-667.7%	·	·
Pretax Margin	·	-1168850.0%	·	·	-667.7%	·	·
EBITDA Margin	·	-1179818.2%	-330039.0%	·	-637.3%	·	·
ROA	-39.6%	-43.2%	-48.3%	·	-22.7%	-25.7%	-24.8%
ROE	-59.9%	-58.1%	-59.9%	·	-27.3%	-22.8%	-29.6%
ROIC	-71.5%	-64.8%	·	·	-27.9%	-23.9%	-32.1%

Liquidità e Solvibilità 2

Metrica	Tendenza	2025	2024	2023	2022	2021	2020	2019
Current Ratio		7.9	8.5	12.4	·	9.8	9.0	16.5
Quick Ratio		1.6	2.1	2.2	·	9.5	8.8	16.0

Efficienza 1

Metrica	Tendenza	2025	2024	2023	2022	2021	2020	2019
Asset Turnover		0.0	0.0	0.0	·	0.0	·	·

Per Azione 6

Metrica	2025	2024	2023	2022	2021	2020	2019
Book Value / Share	$1.28	$1.99	$3.04	·	$6.43	$7.69	$5.06
Revenue / Share	$0.00	$0.00	$0.00	·	$0.28	·	·
Cash Flow / Share	$-0.68	$-1.03	$-1.51	·	$-1.36	·	·
Cash / Share	$0.23	$0.35	$0.49	·	$1.22	$1.31	$1.41
Dividend / Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
EPS (TTM)	$-0.87	$-1.32	$-2.09	$-2.38	$-1.34	$-2.63	$-1.83

Tassi di Crescita 2

Metrica	Tendenza	2025	2024	2023	2022	2021	2020	2019
Revenue YoY		·	-76.8%	-39.1%	-99.9%	·	·	·
Revenue CAGR 3Y		·	-94.2%	·	·	·	·	·

Valutazione (TTM) 10

Metrica	2025	2024	2023	2022	2021	2020	2019
Revenue TTM	$0	$22.0K	$95.0K	$156.0K	$114M	$0	$0
Net Income TTM	$-191M	$-258M	$-327M	$-340M	$-182M	$-316M	$-185M
Market Cap	$314M	$452M	$541M	·	$2.13B	$3.55B	$3.23B
P/E	-1.6	-1.6	-1.5	-2.6	-11.1	-9.6	-14.2
P/S	·	20545.8	5698.3	·	18.7	·	·
P/B	1.1	1.1	1.1	·	2.3	3.3	5.1
P / Tangible Book	1.1	1.1	1.1	1.4	2.3	3.5	·
P / Cash Flow	-2.1	-2.3	-2.3	·	-11.5	-30.8	-23.5
P / FCF	-2.1	-2.2	-2.3	·	-10.3	-19.6	-17.2
Earnings Yield	-63.5%	-62.0%	-65.1%	-37.8%	-9.0%	-10.4%	-7.0%

Conto Economico 12

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$5M	·	$0	$0	$0	$0	$0	$0	$0	$22.0K	$21.0K	$22.0K	$22.0K	$30.0K	$-40.0K	$27.0K
R&D Expense	$31M	$32M	$29M	$31M	$40M	$50M	$45M	$45M	$50M	$52M	$55M	$46M	$62M	$80M	$75M	$64M
SG&A Expense	$21M	$14M	$14M	$14M	$14M	$15M	$16M	$16M	$16M	$17M	$17M	$17M	$19M	$19M	$21M	$19M
Operating Expenses	$52M	$46M	$42M	$45M	$57M	$65M	$60M	$72M	$71M	$70M	$85M	$63M	$81M	$99M	$96M	$83M
Operating Income	$-47M	$-46M	$-42M	$-45M	$-57M	$-65M	$-60M	$-72M	$-71M	$-70M	$-85M	$-63M	$-81M	$-99M	$-96M	$-83M
Other Non-op	$-61.0K	$212.0K	$247.0K	$-81.0K	$-43.0K	$92.0K	$-2M	$-1M	$85.0K	$-929.0K	$-12M	$-5M	$-2M	$2M	$-10M	$-3M
Net Income	$-43M	$-43M	$-39M	$-41M	$-51M	$-60M	$-60M	$-66M	$-66M	$-65M	$-86M	$-62M	$-79M	$-100M	$-103M	$-84M
EPS (Basic)	$-0.13	$-0.18	$-0.17	$-0.19	$-0.23	$-0.28	$-0.27	$-0.32	$-0.35	$-0.38	$-0.49	$-0.37	$-0.54	$-0.69	$-0.72	$-0.59
EPS (Diluted)	$-0.13	$-0.18	$-0.17	$-0.19	$-0.23	$-0.28	$-0.27	$-0.32	$-0.35	$-0.38	$-0.49	$-0.37	$-0.54	$-0.69	$-0.72	$-0.59
Shares (Basic)	328,930,269	240,290,782	·	222,038,680	218,929,548	215,358,619	·	209,188,551	190,026,638	169,128,362	·	167,649,010	146,795,826	144,563,829	·	143,661,721
Shares (Diluted)	328,930,269	240,290,782	·	222,038,680	218,929,548	215,358,619	·	209,188,551	190,026,638	169,128,362	·	167,649,010	146,795,826	144,563,829	·	143,661,721
EBITDA	$-47M	$-43M	·	$-45M	$-57M	$-62M	·	$-72M	$-71M	$-70M	·	$-63M	$-81M	$-99M	·	$-82M

Stato Patrimoniale 19

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$39M	$30M	$52M	$38M	$52M	$42M	$75M	$51M	$171M	$51M	$83M	$69M	$155M	$110M	$62M	$74M
Prepaid Expense	$7M	$6M	$8M	$9M	$10M	$12M	$11M	$13M	$12M	$11M	$10M	$8M	$10M	$10M	$12M	$17M
Current Assets	$340M	$273M	$258M	$261M	$283M	$292M	$303M	$304M	$457M	$395M	$459M	$473M	$502M	$481M	$529M	$569M
PP&E (Net)	$67M	$70M	$73M	$76M	$79M	$83M	$86M	$89M	$92M	$96M	$99M	$103M	$106M	$110M	$113M	$114M
PP&E (Gross)	$145M	$145M	$145M	$145M	$146M	$149M	$149M	$149M	$148M	$151M	$151M	$150M	$150M	$150M	$150M	$149M
Accum. Depreciation	$78M	$75M	$73M	$70M	$67M	$66M	$63M	$60M	$56M	$55M	$51M	$48M	$44M	$40M	$37M	$35M
Other Non-current Assets	$4M	$4M	$4M	$4M	$4M	$2M	$2M	$5M	$6M	$5M	$7M	$10M	$9M	$9M	$10M	$9M
Total Assets	$550M	$396M	$416M	$440M	$471M	$508M	$549M	$589M	$647M	$586M	$643M	$712M	$771M	$747M	$822M	$888M
Accounts Payable	$6M	$5M	$4M	$4M	$5M	$5M	$5M	$6M	$13M	$6M	$6M	$6M	$10M	$15M	$14M	$11M
Current Liabilities	$32M	$28M	$33M	$32M	$32M	$30M	$36M	$33M	$37M	$31M	$37M	$38M	$55M	$60M	$54M	$49M
Capital Leases	$70M	$73M	$75M	$77M	$79M	$81M	$83M	$85M	$87M	$89M	$88M	$90M	$92M	$94M	$95M	$97M
Other Non-current Liabilities	$12M	$16M	$16M	$15M	$15M	$11M	$8M	$8M	$8M	$5M	$5M	$1M	$2M	$2M	$6M	$2M
Total Liabilities	$114M	$117M	$123M	$124M	$126M	$123M	$127M	$125M	$132M	$125M	$131M	$129M	$148M	$155M	$155M	$148M
Common Stock	$345.0K	$245.0K	$229.0K	$223.0K	$220.0K	$219.0K	$212.0K	$210.0K	$209.0K	$170.0K	$169.0K	$168.0K	$167.0K	$146.0K	$144.0K	$144.0K
Retained Earnings	$-2.10B	$-2.05B	$-2.01B	$-1.97B	$-1.93B	$-1.88B	$-1.82B	$-1.76B	$-1.69B	$-1.63B	$-1.56B	$-1.47B	$-1.41B	$-1.33B	$-1.23B	$-1.14B
AOCI	$-518.0K	$-183.0K	$269.0K	$235.0K	$-45.0K	$43.0K	$-89.0K	$157.0K	$-780.0K	$-927.0K	$-955.0K	$-2M	$-4M	$-6M	$-10M	$-13M
Stockholders' Equity	$436M	$279M	$293M	$315M	$345M	$385M	$422M	$464M	$515M	$461M	$512M	$583M	$623M	$592M	$667M	$740M
Liabilities + Equity	$550M	$396M	$416M	$440M	$471M	$508M	$549M	$589M	$647M	$586M	$643M	$712M	$771M	$747M	$822M	$888M
Shares Outstanding	345,345,427	244,816,413	229,413,523	223,163,672	220,133,876	218,598,262	212,210,597	209,500,137	209,049,485	170,452,967	168,642,238	168,175,221	167,133,664	145,740,333	144,438,304	144,031,588

Flusso di cassa 12

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$4M	$4M	$3M	$4M	·	·	·	·
Stock-based Comp	$12M	$8M	$8M	$9M	$9M	$12M	$13M	$13M	$14M	$12M	$15M	$15M	$17M	$19M	$17M	$21M
Restructuring	·	·	$0	$0	·	·	·	·	·	·	·	·	·	·	·	·
Other Non-cash	·	$19M	·	·	·	$-8M	·	·	·	·	·	·	·	·	·	·
Operating Cash Flow	$-32M	$-13M	$-28M	$-30M	$-39M	$-53M	$-37M	$-44M	$-64M	$-56M	$-54M	$-56M	$-62M	$-67M	$-62M	$-48M
CapEx	$150.0K	$9.0K	$0	$243.0K	$44.0K	$99.0K	$257.0K	$429.0K	$0	$8.0K	$181.0K	$12.0K	$288.0K	$1M	$2M	$223.0K
Investing Cash Flow	$-148M	$-30M	$34M	$12M	$44M	$6M	$55M	$-76M	$75M	$22M	$67M	$-34M	$17M	$113M	$50M	$25M
Stock Issued	·	·	·	·	·	$10M	·	·	·	$0	·	$3M	·	·	$0	$0
Net Stock Activity	·	·	·	·	·	$10M	·	·	·	·	·	·	·	·	·	·
Financing Cash Flow	$188M	$21M	$8M	$3M	$5M	$14M	$6M	$679.0K	$109M	$2M	$155.0K	$4M	$90M	$2M	$46.0K	$1M
Net Change in Cash	$8M	$-21M	$14M	$-15M	$10M	$-33M	$24M	$-119M	$120M	$-32M	$14M	$-86M	$45M	$48M	$-12M	$-22M
Free Cash Flow	·	$-13M	·	·	·	$-53M	·	·	·	$-56M	·	·	·	$-68M	·	·

Redditività 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Operating Margin	-1011.2%	·	·	·	·	·	·	·	·	-315927.3%	·	-146453.5%	-182995.5%	-190519.2%	·	-168344.9%
Net Margin	-919.8%	·	·	·	·	·	·	·	·	-295454.6%	·	-142593.0%	-177247.7%	-189815.4%	·	-169689.8%
EBITDA Margin	-1011.2%	·	·	·	·	·	·	·	·	-315927.3%	·	-146453.5%	-182995.5%	-190519.2%	·	-168344.9%
ROA	-8.4%	-9.4%	·	-8.1%	-9.1%	-10.9%	·	-10.2%	-9.4%	-9.8%	·	-7.7%	-9.1%	-11.5%	·	-8.5%
ROE	-10.9%	-12.8%	·	-10.6%	-11.8%	-14.1%	·	-12.7%	-11.7%	-12.3%	·	-9.3%	-10.9%	-13.6%	·	-9.7%

Liquidità e Solvibilità 2

Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio		10.7	9.6	·	8.2	8.9	9.7	·	9.3	12.3	12.8	·	12.6	9.2	8.1	·	11.6
Quick Ratio		1.2	1.1	·	1.2	1.7	1.4	·	1.6	4.6	1.7	·	1.8	2.8	1.8	·	1.5

Efficienza 1

Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.0	·	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.0	0.0	0.0	·	0.0

Per Azione 5

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$1.26	$1.14	·	$1.41	$1.57	$1.76	·	$2.21	$2.46	$2.71	·	$3.47	$3.73	$4.06	·	$5.14
Revenue / Share	$0.01	·	·	$0.00	$0.00	$0.00	·	$0.00	$0.00	$0.00	·	$0.00	$0.00	$0.00	·	$0.00
Cash Flow / Share	·	$-0.05	·	·	·	$-0.25	·	·	·	$-0.33	·	·	·	$-0.46	·	·
Cash / Share	$0.11	$0.12	·	$0.17	$0.24	$0.19	·	$0.24	$0.82	$0.30	·	$0.41	$0.93	$0.75	·	$0.52
EPS (TTM)	$-0.67	$-0.77	·	$-0.97	$-1.10	$-1.22	·	$-1.54	$-1.59	$-1.78	·	$-2.32	$-2.54	$-2.56	·	$-1.70

Valutazione (TTM) 9

Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	·	$0	·	$0	$0	$0	·	$43.0K	$65.0K	$87.0K	·	$34.0K	$39.0K	$81.0K	·	$76M
Net Income TTM	$-165M	$-174M	·	$-212M	$-237M	$-252M	·	$-283M	$-279M	$-292M	·	$-344M	$-366M	$-367M	·	$-243M
Market Cap	$718M	$597M	·	$277M	$249M	$319M	·	$587M	$487M	$762M	·	$533M	$831M	$720M	·	$1.56B
P/E	-3.1	-3.2	·	-1.3	-1.0	-1.2	·	-1.8	-1.5	-2.5	·	-1.4	-2.0	-1.9	·	-6.4
P/S	·	·	·	·	·	·	·	13641.9	7493.6	8757.8	·	15679.9	21298.8	8888.4	·	20.5
P/B	1.6	2.1	·	0.9	0.7	0.8	·	1.3	0.9	1.7	·	0.9	1.3	1.2	·	2.1
P / Tangible Book	1.6	2.1	·	0.9	0.7	0.8	·	1.3	0.9	1.7	·	0.9	1.3	1.2	·	2.1
P / Cash Flow	·	-46.3	·	·	·	-6.0	·	·	·	-13.6	·	·	·	-10.8	·	·
Earnings Yield	-32.2%	-31.6%	·	-78.2%	-97.4%	-83.6%	·	-55.0%	-68.2%	-39.8%	·	-73.2%	-51.1%	-51.8%	·	-15.7%

Periodo più recente a sinistra · valori nulli mostrati come ·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

16

Metrica	2025-12-31	2024-12-31	2023-12-31	2023-09-30	2023-06-30
Ricavi	$0	$22.0K	$95.0K	·	·
Margine Operativo %	·	-1241813.6%	-344986.3%	·	·
Utile netto	$-191M	$-258M	$-327M	·	·
EPS Diluito	$-0.87	$-1.32	$-2.09	·	·

Metrica	2025-12-31	2024-12-31	2023-12-31	2023-09-30	2023-06-30
Rapporto corrente	7.9	8.5	12.4	·	·
Quick Ratio	1.6	2.1	2.2	·	·

Metrica	2025-12-31	2024-12-31	2023-12-31	2023-09-30	2023-06-30
Flusso di cassa libero	$-150M	$-201M	$-239M	·	·

Proprietari istituzionali (13F) 228 filer · $652.3M totale · Aggiornato al 30 Giugno 2026

17

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Detentori 228

Valore detenuto $652.3M

Nuove posizioni 34

Posizioni chiuse 27

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
34 (-18 vs trimestre precedente)	27 (+16 vs trimestre precedente)	100 (+19 vs trimestre precedente)	51 (+10 vs trimestre precedente)	+129.2M

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
BlackRock, Inc.	$62.705.681	30.146.963	9,61%	Azioni
Pfizer Inc	$46.928.245	22.032.040	7,19%	Azioni
Frazier Life Sciences Management, L.P.	$46.689.069	22.446.668	7,16%	Azioni
STATE STREET CORP	$39.573.718	19.025.826	6,07%	Azioni
TPG GP A, LLC	$38.929.916	18.716.306	5,97%	Azioni
Sio Capital Management, LLC	$27.712.736	13.323.431	4,25%	Azioni
PRIMECAP MANAGEMENT CO/CA/	$27.296.756	13.123.440	4,18%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$25.306.603	12.166.636	3,88%	Azioni
FMR LLC	$24.978.809	12.009.043	3,83%	Azioni
CITADEL ADVISORS LLC	$20.982.562	10.087.770	3,22%	Azioni
TWO SIGMA INVESTMENTS, LP	$16.191.444	7.784.348	2,48%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$14.666.040	7.049.328	2,25%	Azioni
GOLDMAN SACHS GROUP INC	$12.789.834	6.148.959	1,96%	Azioni
VANGUARD GROUP INC	$12.674.704	9.251.609	1,94%	Azioni
GordonMD Global Investments LP	$11.019.840	5.298.000	1,69%	Azioni
MARSHALL WACE, LLP	$10.598.449	5.095.408	1,62%	Azioni
Patient Square Capital LP	$10.504.000	5.050.000	1,61%	Azioni
Aberdeen Group plc	$10.403.644	5.001.752	1,60%	Azioni
MILLENNIUM MANAGEMENT LLC	$10.075.289	4.843.889	1,54%	Azioni
D. E. Shaw & Co., Inc.	$9.798.329	4.710.735	1,50%	Azioni
MORGAN STANLEY	$9.380.720	4.509.962	1,44%	Azioni
Woodline Partners LP	$9.361.298	4.500.624	1,44%	Azioni
Candriam S.C.A.	$9.010.818	4.336.296	1,38%	Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC	$8.761.122	4.212.078	1,34%	Azioni
RENAISSANCE TECHNOLOGIES LLC	$7.975.369	3.834.312	1,22%	Azioni
Walleye Capital LLC	$6.797.465	3.268.012	1,04%	Azioni
RTW INVESTMENTS, LP	$6.760.000	3.250.000	1,04%	Azioni
DIMENSIONAL FUND ADVISORS LP	$6.740.207	3.239.077	1,03%	Azioni
BANK OF AMERICA CORP /DE/	$6.629.626	3.187.320	1,02%	Azioni
UBS Group AG	$6.319.855	3.038.392	0,97%	Azioni
Ghisallo Capital Management LLC	$6.240.000	3.000.000	0,96%	Azioni
NORTHERN TRUST CORP	$6.146.986	2.955.282	0,94%	Azioni
Wildcat Capital Management, LLC	$6.075.237	2.920.787	0,93%	Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$4.730.675	2.274.363	0,73%	Azioni
AQR CAPITAL MANAGEMENT LLC	$4.173.079	2.006.288	0,64%	Azioni
DAFNA Capital Management LLC	$4.160.000	2.000.000	0,64%	Azioni
TWO SIGMA ADVISERS, LP	$3.959.574	2.890.200	0,61%	Azioni
VANGUARD FIDUCIARY TRUST CO	$3.823.756	1.838.344	0,59%	Azioni
JPMORGAN CHASE & CO	$3.193.323	1.438.434	0,49%	Azioni
Boxer Capital Management, LLC	$3.120.000	1.500.000	0,48%	Azioni
JACOBS LEVY EQUITY MANAGEMENT, INC	$3.026.614	1.455.103	0,46%	Azioni
Raiffeisen Bank International AG	$2.442.000	1.100.000	0,37%	Azioni
Vida Ventures Advisors, LLC	$2.229.722	1.798.163	0,34%	Azioni
Invesco Ltd.	$1.607.395	772.786	0,25%	Azioni
Bank of New York Mellon Corp	$1.512.540	727.182	0,23%	Azioni
Man Group plc	$1.459.954	701.901	0,22%	Azioni
RAYMOND JAMES FINANCIAL INC	$1.412.262	678.972	0,22%	Azioni
Nuveen, LLC	$1.299.268	624.648	0,20%	Azioni
IEQ CAPITAL, LLC	$1.207.172	580.371	0,19%	Azioni
Mitsubishi UFJ Asset Management Co., Ltd.	$1.138.153	547.189	0,17%	Azioni

Mostra tutti i 228 proprietari istituzionali →

Attivisti e proprietari del 5%+ 6 partecipazioni

18

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante	Depositato	Partecipazione	Stato	Scopo	Deposito
James G. Coulter, Jon Winkelried, TPG GP A, LLC	30 Settembre 2026	0,00%	Modifica	·	SEC
Pfizer Inc.	13 Febbraio 2026	9,00%	Modifica	·	SEC
Pfizer Inc. (“Pfizer”) ×3 depositi	25 Ottobre 2023	·	Deposito iniziale	·	SEC
TPG GP A, LLC, David Bonderman, James G. Coulter, Jon Winkelried	18 Gennaio 2022	·	Deposito iniziale	·	SEC
TPG Group Holdings (SBS) Advisors, Inc., David Bonderman, James G. Coulter ×4 depositi	10 Agosto 2020	·	Deposito iniziale	·	SEC
Pfizer Inc. (“ Pfizer ”)	22 Ottobre 2018	·	Deposito iniziale	Investimento passivo	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Insider aziendali 23 insider · 13 dirigenti · 8 direttori

19

Insider	Ruolo	Ultima attività	Azioni possedute	Vendite 12m	Netto 12m
Zachary Roberts	President and CEO	01 Luglio 2026 A	581.166	2	$-104.169
David D Chang	President and CEO	16 Marzo 2026 S	5.150.599	2	$-289.459
Geoffrey M. Parker	CHIEF FINANCIAL OFFICER	02 Febbraio 2026 A	1.252.795	2	$-88.539
Eric Thomas Schmidt	Chief Financial Officer	22 Marzo 2023 A	862.439	0	$0
Earl Martin Douglas	SVP, General Counsel	21 Agosto 2026 S	488.267	2	$-103.262
Annie Yoshiyama	SVP, Finance	21 Aprile 2026 S	124.517	2	$-29.311
Benjamin Machinas Beneski	SVP, Chief Technical Officer	31 Marzo 2026 S	195.338	5	$-51.672
Timothy L. Moore	Chief Technical Officer	03 Febbraio 2025 S	250.713	0	$0
Yinlin Jack Chen	SVP, Finance	10 Agosto 2023 A	88.881	0	$0
Lillian Smith	VP, Corporate Counsel	01 Aprile 2023 A	140.390	0	$0
Alison Moore	Chief Technical Officer	22 Marzo 2023 A	672.731	0	$0
Veer Bhavnagri	General Counsel	14 Marzo 2023 F	556.049	0	$0
Rafael Amado	EVP of R&D	07 Ottobre 2022 F	541.946	0	$0
Stephen Mayo	Direttore	18 Giugno 2026 A	25.328	0	$0
Elizabeth A. Barrett	Direttore	18 Giugno 2026 A	·	0	$0
Deborah M. Messemer	Direttore	18 Giugno 2026 A	107.431	0	$0
Owen N. Witte	Direttore	18 Giugno 2026 A	292.832	0	$0
Franz B Humer	Direttore	18 Giugno 2026 A	307.507	0	$0
Joshua A Kazam	Direttore	18 Giugno 2026 A	398.463	0	$0
Vicki L Sato	Direttore	18 Giugno 2026 A	162.575	0	$0
PF Equity Holdings 2 B.V.	Proprietario del 10%	31 Marzo 2022 J	0	0	$0
Pfizer Inc.	Proprietario del 10%	15 Ottobre 2018 C	22.032.040	0	$0
Arie Belldegrun	·	02 Febbraio 2026 A	2.236.816	0	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Proprietà ETF Posseduti da 22 ETF

20

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
BBC · ETFis Series Trust I	0,66%	163.586 NS	31 Luglio 2026	N-PORT
LABU · Direxion Shares ETF Trust	0,16%	412.615 NS	31 Luglio 2026	N-PORT
VFMO · VANGUARD WELLINGTON FUND	0,05%	496.849 SH	19 Agosto 2026	Giornaliero
PWS · Pacer Funds Trust	0,04%	5.637 NS	31 Luglio 2026	N-PORT
VTWV · VANGUARD SCOTTSDALE FUNDS	0,04%	231.043 SH	19 Agosto 2026	Giornaliero
PRFZ · Invesco Exchange-Traded Fund Trust	0,04%	671.465 SH	02 Ottobre 2026	Giornaliero
IBBQ · Invesco Exchange-Traded Fund Trust …	0,04%	24.445 SH	02 Ottobre 2026	Giornaliero
IBB · iShares Trust	0,03%	1.977.547 SH	11 Settembre 2026	Giornaliero
VTWO · VANGUARD SCOTTSDALE FUNDS	0,02%	1.528.157 SH	19 Agosto 2026	Giornaliero
OMFS · Invesco Exchange-Traded Self-Indexe…	0,02%	27.831 SH	02 Ottobre 2026	Giornaliero
IWM · iShares Trust	0,02%	6.789.955 SH	11 Settembre 2026	Giornaliero
DFAS · Dimensional ETF Trust	0,01%	1.028.485 NS	31 Luglio 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,01%	3.222.860 SH	19 Agosto 2026	Giornaliero
VHT · VANGUARD WORLD FUND	0,01%	776.881 SH	19 Agosto 2026	Giornaliero
DFAC · Dimensional ETF Trust	0,00%	241.276 NS	31 Luglio 2026	N-PORT
ITOT · iShares Trust	0,00%	356.622 SH	11 Settembre 2026	Giornaliero
DFUS · Dimensional ETF Trust	0,00%	71.758 NS	31 Luglio 2026	N-PORT
IWV · iShares Trust	0,00%	25.550 SH	03 Settembre 2026	Giornaliero
VTI · VANGUARD INDEX FUNDS	0,00%	8.666.591 SH	19 Agosto 2026	Giornaliero
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	22.307 SH	19 Agosto 2026	Giornaliero
IWN · iShares Trust	·	2.464.664 SH	11 Settembre 2026	Giornaliero
SMLF · iShares Trust	·	484.475 SH	11 Settembre 2026	Giornaliero

ALLO Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

21

rating · 18 analisti COMPRA

Target mediano $9.00 +500,0%

6 33,3% Acquisto forte

10 55,6% Compra

2 11,1% Mantieni

0 0,0% Vendi

0 0,0% Vendita forte

Target Price a 12 Mesi

9 analisti · 2026-10-03

Target medio $9.00 +500,0%

← Sotto tutti i target Prezzo attuale $1.50

Basso$4.00 Media$9.00 Alto$14.00

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

22

Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
ALLO	$314M	-1.6	-76.8%	·	-59.9%	·
SGMT	·	-3.7	·	·	-42.3%	·
CTMX	$725M	·	-44.8%	-22.8%	-15.9%	·
PRME	$626M	-2.6	55.3%	-4342.4%	-221.4%	·
ALT	$400M	-3.6	105.0%	-214861.0%	-45.6%	·
MPLT	$773M	-0.9	·	·	-151.1%	·
MNPR	·	·	·	·	·	·
CBIO	$327M	-24.2	-86.7%	-1419.6%	-90.0%	·
NGNE	$319M	-4.9	·	·	-33.6%	·
ZURA	·	·	·	·	·	·
CAPR	$1.66B	-12.8	-11.6%	·	-51.1%	·

Ultime notizie Notizie recenti che menzionano questa società

23

Allogene Therapeutics (ALLO): 10 Migliori Growth Stocks Sotto 10$ in Cui Investire Yahoo Finance · 5 mesi, 1 settimana fa

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

26

Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

ALLO Allogene Therapeutics, Inc. - Common Stock